Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blinded, two-center trial to evaluate the
gonadotropin suppressive activity of transdermal treatment with a combined NES/T gel, or T
gel alone, for 28 days.
Phase:
Phase 1
Details
Lead Sponsor:
Health Decisions
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)